BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32436862)

  • 21. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Xu R; Chen L; Yang WT
    Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B.
    Hu Y; Li Y; Huang Y; Jin Z; Wang C; Wang H; Xu J
    Eur J Pharmacol; 2020 Jul; 879():173134. PubMed ID: 32339511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANP32B promotes lung cancer progression by regulating VDAC1.
    Li T; Wang N; Li S; Yan H; Gao S; Gao W; Xu R
    Gene; 2023 Apr; 859():147200. PubMed ID: 36642319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [KMT2A Activates Akt/mTOR Signaling Pathway Through LncRNA-HOTAIR to Influence the Biological Behavior of AML Cells].
    Huang Y; Zhang AL; Su R; Zhang LJ; Zou R; Wang SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):. PubMed ID: 35680797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.
    Lin W; Francis JM; Li H; Gao X; Pedamallu CS; Ernst P; Meyerson M
    Cancer Biol Ther; 2016 Dec; 17(12):1274-1281. PubMed ID: 27801610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CoQ
    Hseu YC; Thiyagarajan V; Ou TT; Yang HL
    Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.
    Zhou C; Li G; Zhou J; Han N; Liu Z; Yin J
    PLoS One; 2014; 9(11):e111860. PubMed ID: 25386925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer.
    Chen Y; Liu F; Wu K; Wu W; Wu H; Zhang W
    J Gene Med; 2018 Dec; 20(12):e3056. PubMed ID: 30225951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
    Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
    Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.
    Chen M; Zhang Y; Zheng PS
    PLoS One; 2017; 12(5):e0177171. PubMed ID: 28489874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway.
    Zhou Y; An Q; Guo RX; Qiao YH; Li LX; Zhang XY; Zhao XL
    Life Sci; 2017 Feb; 171():9-15. PubMed ID: 28082020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
    Cai X; Zhu S
    Genomics; 2023 May; 115(3):110595. PubMed ID: 36871636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells.
    Tan Y; Wang H; Zhang C
    Environ Toxicol Pharmacol; 2021 Jan; 81():103514. PubMed ID: 33086148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.
    Wang X; Xia Y
    Biochem Biophys Res Commun; 2016 Jun; 475(2):169-75. PubMed ID: 27181358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
    Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
    Ju W; Luo X; Zhang N
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.